Literature DB >> 35844274

Skin Conditions and Movement Disorders: Hiding in Plain Sight.

Kristina Kulcsarova1,2, Janette Baloghova3,4, Jan Necpal5, Matej Skorvanek1,2.   

Abstract

Skin manifestations are well-recognized non-motor symptoms of Parkinson's disease (PD) and other hypokinetic and hyperkinetic movement disorders. Skin conditions are usually well visible during routine clinical examination and their recognition may play a major role in diagnostic work-up. In this educational review we: (1) briefly outline skin conditions related to Parkinson's disease, including therapy-related skin complications and their management; (2) discuss the role of skin biopsies in early diagnosis of PD and differential diagnosis of parkinsonian syndromes; and focus more on areas which have not been reviewed in the literature before, including (3) skin conditions related to atypical parkinsonism, and (4) skin conditions related to hyperkinetic movement disorders. In case of rare hyperkinetic movement disorders, specific dermatological manifestations, like presence of angiokeratomas, telangiectasias, Mongolian spots, lipomas, ichthyosis, progeroid skin changes and others may point to a very specific group of disorders and help guide further investigations.
© 2022 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  atypical parkinsonism; hyperkinetic; movement disorders; skin; skin biopsy

Year:  2022        PMID: 35844274      PMCID: PMC9274368          DOI: 10.1002/mdc3.13436

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  150 in total

1.  European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019.

Authors:  Claus Garbe; Teresa Amaral; Ketty Peris; Axel Hauschild; Petr Arenberger; Lars Bastholt; Veronique Bataille; Veronique Del Marmol; Brigitte Dréno; Maria Concetta Fargnoli; Jean-Jacques Grob; Christoph Höller; Roland Kaufmann; Aimilios Lallas; Celeste Lebbé; Josep Malvehy; Mark Middleton; David Moreno-Ramirez; Giovanni Pellacani; Philippe Saiag; Alexander J Stratigos; Ricardo Vieira; Iris Zalaudek; Alexander M M Eggermont
Journal:  Eur J Cancer       Date:  2020-01-09       Impact factor: 9.162

Review 2.  Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature.

Authors:  M Agopiantz; P Corbonnois; A Sorlin; C Bonnet; M Klein; N Hubert; V Pascal-Vigneron; P Jonveaux; T Cuny; B Leheup; G Weryha
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

Review 3.  Progressive supranuclear palsy.

Authors:  Nikolaos Giagkou; Günter U Höglinger; Maria Stamelou
Journal:  Int Rev Neurobiol       Date:  2019-11-21       Impact factor: 3.230

4.  Intermittent dystonia in Hartnup disease.

Authors:  B T Darras; M G Ampola; W H Dietz; H E Gilmore
Journal:  Pediatr Neurol       Date:  1989 Mar-Apr       Impact factor: 3.372

5.  NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.

Authors:  Ji Zhou; Jiuwei Li; Sarah L Stenton; Xiaotun Ren; Shuai Gong; Fang Fang; Holger Prokisch
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

Review 6.  Incontinentia pigmenti and hypomelanosis of Ito.

Authors:  Christine Bodemer
Journal:  Handb Clin Neurol       Date:  2013

7.  Hypertrichosis in patients with SURF1 mutations.

Authors:  Elsebet Ostergaard; Irena Bradinova; Susanne Holst Ravn; Flemming Juul Hansen; Emil Simeonov; Ernst Christensen; Flemming Wibrand; Marianne Schwartz
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

8.  Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.

Authors:  Joanne Trinh; Sophie Imhoff; Marija Dulovic-Mahlow; Krishna Kumar Kandaswamy; Vera Tadic; Jochen Schäfer; Valerija Dobricic; Achim Nolte; Martin Werber; Arndt Rolfs; Alexander Münchau; Christine Klein; Katja Lohmann; Norbert Brüggemann
Journal:  J Neurol       Date:  2019-11-20       Impact factor: 4.849

Review 9.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

Review 10.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.